MXL

Maxlinear, Inc Information Technology Semiconductors & Related Devices Russell 3000
$67.47Close $5.8BMarket cap $13.05 – $128.0352-week range Jan 21, 2027Next report · estimated

Highlights

Strengths

  • Leading the market RS 99 · stronger than 99% of stocks over 12 months

Cautions

  • Not in an uptrend 5 of 8 trend conditions
  • Far from its high 47% below its 52-week high

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 22, 2026
Off 12-month high 47%
1wk up 6.3% price change
1mo down 25.3% price change
12-month return up 342% market up 11% · its own up 333%
F-score 5 / 9 Mixed
Altman Z 9.44 Low risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 12.9× price / book
Earnings yield down 2.2% EBIT / enterprise value
Cheaper than 18% of the market · expensive
Revenue growth up 30% year on year
EPS growth — latest quarter
Sales growth up 72% latest quarter · +17 pts
ROE down 28% return on equity
Free cash margin up 2% $7.0M FCF
D/E 0.27 long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • took on more long-term debt
  • short-term liquidity weakened
  • issued more shares
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • gross margin widened
  • assets working harder

Repair signals

  • FCF turned positive ($-63M → $7M)
  • Gross margin 54.0% → 56.8%
  • Revenue reaccelerating (-48% then +30%)

Trade setup

ATR% 11.2% $7.54 a day · 2×ATR $52.40
RS 99 / 99 vs the universe
Trend 5 / 8 under the 150/200-day, under the 50-day, over 25% off the high
Relative volume 0.9× vs 50-day average
Up/down volume 1.12 50 sessions
Implied move — no scheduled report
Trend template · 5 of 8
  • Price above the 150 and 200-day averages: fails
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: passes
  • 50-day average above the 150 and 200-day: passes
  • Price above the 50-day average: fails
  • At least 30% above the 52-week low: passes
  • Within 25% of the 52-week high: fails
  • RS rank 70 or higher: passes

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Shareholders diluted The share count rose 2.2% over the year, from 85m to 86m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported Oct 22, 2026
Last shock Jul 24, 2026-22% in one session2.6× volumeon results-6% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $467.6M +30% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $478.6M FY2021 · $892.4M FY2022 · $1.1B FY2023 · $693.3M FY2024 · $360.5M FY2025 · $467.6M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$136.7M
-$250M $0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$98.6M FY2021 · $42.0M FY2022 · $125.0M FY2023 · -$73.1M FY2024 · -$245.2M FY2025 · -$136.7M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $7.0M back to a profit
-$100M $0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $61.1M FY2021 · $129.1M FY2022 · $347.5M FY2023 · $29.9M FY2024 · -$63.0M FY2025 · $7.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 57%
  • Net -29%
  • Free cash 2%
-100% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 44% · Net -21% · Free cash 13% FY2021 · Gross 56% · Net 5% · Free cash 14% FY2022 · Gross 58% · Net 11% · Free cash 31% FY2023 · Gross 56% · Net -11% · Free cash 4% FY2024 · Gross 54% · Net -68% · Free cash -17% FY2025 · Gross 57% · Net -29% · Free cash 2%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $50.8M net debt
  • Cash
  • Long-term debt
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $148.9M · Long-term debt $363.6M FY2021 · Cash $130.6M · Long-term debt $306.2M FY2022 · Cash $187.4M · Long-term debt $121.8M FY2023 · Cash $187.3M · Long-term debt $122.4M FY2024 · Cash $118.6M · Long-term debt $123.0M FY2025 · Cash $72.8M · Long-term debt $123.6M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 86.45m +16.0% since FY2020
86.45m 74.54m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 74.54m FY2021 · 76.78m FY2022 · 78.75m FY2023 · 81.82m FY2024 · 84.61m FY2025 · 86.45m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $478.6M $892.4M $1.1B $693.3M $360.5M $467.6M
Gross margin 44% 56% 58% 56% 54% 57%
Operating income -$101.1M $65.2M $180.2M -$38.2M -$223.4M -$126.9M
Net income -$98.6M $42.0M $125.0M -$73.1M -$245.2M -$136.7M
Net margin -21% 5% 11% -11% -68% -29%
Earnings per share -$1.35 $0.53 $1.55 -$0.91 -$2.93 -$1.58
Free cash flow $61.1M $129.1M $347.5M $29.9M -$63.0M $7.0M
Free cash margin 13% 14% 31% 4% -17% 2%
Cash $148.9M $130.6M $187.4M $187.3M $118.6M $72.8M
Long-term debt $363.6M $306.2M $121.8M $122.4M $123.0M $123.6M
Shareholders' equity $391.1M $489.2M $676.4M $686.3M $516.3M $451.9M
Shares outstanding 74.54m 76.78m 78.75m 81.82m 84.61m 86.45m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 22, 2026 Quarterly ↗ Sep 30, 2026 22d
Jul 23, 2026 Quarterly ↗ Jun 30, 2026 23d
Apr 23, 2026 Quarterly ↗ Mar 31, 2026 23d
Jan 29, 2026 Annual ↗ Dec 31, 2025 29d
Oct 23, 2025 Quarterly ↗ Sep 30, 2025 23d
Jul 23, 2025 Quarterly ↗ Jun 30, 2025 23d
Apr 23, 2025 Quarterly ↗ Mar 31, 2025 23d
Jan 29, 2025 Annual ↗ Dec 31, 2024 29d
Oct 23, 2024 Quarterly ↗ Sep 30, 2024 23d
Jul 24, 2024 Quarterly ↗ Jun 30, 2024 24d
Apr 24, 2024 Quarterly ↗ Mar 31, 2024 24d
Jan 31, 2024 Annual ↗ Dec 31, 2023 31d

Current reports